MANAGEMENT DISCUSSIONS & ANALYSIS:

This report contains financial review, opportunities, challenge, outlook etc.

i)FINANCIAL REVIEW:

Income earned to the extent of Rs. 1,354.32 lakhs as against 647.09 lakhs of brvious year.

ii)PERFORMANCE:

During the year under review your company recorded a turnover of Rs. 1,354.32 Lakhs as against Rs. 647.09 Lakhs for the brvious financial year. The turnover includes the Clinical Research services, Education Services, HR Staffing Services and Data Management Service charges. The Business plan is to ensure at least two fold growth in business in the coming year(s) with the stable business.

Your company has moved into a new independent brmise in December 2014, with a 10 year lease term, near Manikonda, spanning over 22,000 square feet.

During the Financial Year under report, Clinical Research Services division has expanded into offering the complete portfolio of services as explained below:

Jeevan has the advantage of fully integrated scientific expertise team in Clinical research functions. Jeevan offers a varied range of clinical research services across Phase I to Phase IV services to pharmaceutical and biotechnology industries. The technical team at Jeevan has immense experience in handling various projects in diverse therapeutic areas for different regulatory authorities. The leadership team at Jeevan has over 125 years of cumulative experience in this arena, which comprises successful execution of more than 1500 clinical research projects for several pharma clients across the globe.

a)Bioanalytical Research

Your company has started a Bioanalytical Lab in the new brmises. Bioanalytical research laboratory is designed with state of the art facility equipped with advanced analytical instrumentation having 2 processing labs and 4 LC-MS/MS labs, which can accommodate up to 12 LC-MS/MS.Jeevan Scientific offers a unique combination of highly trained workforce enabled with well-equipped bioanalytical research and development (R&D) laboratory.

b)Clinical Operations

Jeevan's Clinical operation team has a vast experience in executing clinical projects of different therapeutic areas across the globe. Jeevan has rich pool of clinical investigators experienced in handling various phases of clinical projects including Pharmacokinetic and Pharmacodynamic studies in wide range of therapeutic areas.

c)Clinical Project Management

The Project management team is responsible for overseeing the technical and administrative aspects of the study. The team is committed to ensure timely update of project status, and meeting the client requirements in agreed timelines.

d)Quality Assurance Services

The QA team is focussed on continual improvement of Quality Management System and reports directly to management. QA auditors are armed with knowledge on national, international regulations and guidelines. The QA team audits quality systems and studies, carried out by Jeevan, in accordance with set procedures and applicable regulatory guidelines, to ensure fulfilment of quality requirements.

e)Scientific and Medical Writing Services

Jeevan's Scientific and Medical Writing Services are structured with a team of competent writers, with diverse portfolios. The team is currently supporting major pharma clients across the globe, to achieve their objectives in scientific communications and providing assistance in varied writing services including Commercialization writing, Regulatory & technical documents along with other client customized documentations. Already your company is working with the following clients from the past 3 years:

i. Novo Nordisk, India

ii.Novo Nordisk, UAE

iii.Novo Nordisk, Iran

iv.Pfizer, India

v.Bayer Healthcare, India

vi.Dr. Reddy's Laboratories, India

vii.Sanofi Aventis, India

viii.Novartis, India

ix.Sava Health Care, India

x.Apollo Hospitals, Hyderabad

xi.Individual Doctors

f) Clinical Data Management and Statistical Analysis Services

The Data Management team has hands on experience in handling clinical data, and the team ensures efficient and reliable management of the data in compliance with industry standards and regulatory requirements. Your company offers full clinical data management services for all types of studies from routine phase I trials through to large and complex phase III trials, as well as non-interventional studies.

g) Pharmacovigilance Services:

Jeevan scientific offers a wide range of combrhensive pharmacovigilance and safety monitoring services. Jeevan's aim at a rapid pace growth, and retains an experienced vigilance team, thus being able to provide a wide range Pharmacovigilance services for different regulatory bodies.

h) Regulatory Affairs:

Jeevan provide expert services for the management of concerns with regulatory authorities and fulfill client expectations in a realistic and transparent manner.

Other Services:

During the Financial Year under report, the Annamalai University has been taken over by the Government of Tamilnadu, due to which several administrative changes has happened in the respective university and your company is contemplating to reduce the focus on this business and keep more focus on the Clinical Research and Information Technology Services.

During the Financial Year under report your company has decided to discontinue these services going forward to keep more focus on the Clinical Research and Information Technology Services.

A.OPPORTUNITIES:

Your Company could visualize increasing opportunities in exploring new avenues in Education Sector, Staffing Services both in Domestic and International and Clinical Research Services. The marketing efforts of the company received an encouraging response.

B.CHALLENGES:

Your Company faces normal market competition in all its business from domestic and overseas companies. Our business strategies and global competitive cost position have enabled us to retain the market position and maintain operating margin and enhance long term, even under difficult operating conditions for the I.T industry, Pharmaceutical and Education Sectors also we intend to diversify and explore other areas to achieve higher revenues. We endeavor to enhance its competitive advantage through a process of continuous improvements and by implementing appropriate business strategies.

C.OUTLOOK:

The outlook for margins in current scenario will depend upon global demand and supply trends in the pharmaceutical / education industry. We intend to extend our educational programs and explore the new avenues and opportunities by entering in to tie-up arrangements with more national and International Universities. In the Clinical research services area we plan to extendour services to a variety of pharmaceutical industries around the world covering all the therapeutic areas.

D.ADEQUACY OF INTERNAL CONTROL:

Your company has internal auditors to ensure that internal control systems are in place and all assets are safeguarded and protected against loss. An extensive program of Internal Auditand reviewssupplement the internal control systems by management & documented policy guidelines and procedures. The internal control systems are designed to ensure that the financial records are available for brparing financial statements and other data and maintaining accountability of assets.

E.QUALITY:

Our Motto is to ensure total Customer Satisfaction. Proactive efforts are directed towards determining customers' requirements and achieving all round customer satisfaction. This is primarily achieved through automated systems, high attention to complaint resolution online communication and information exchange, quality circles and adoption of programs.

F.HUMAN RESOURCES DEVELOPMENT (HRD):

Yours is a young Company, with human resources of an average age of 30 years for its employees as on March 31, 2015. Right from the beginning the Company got good HRD policies for retaining manpower.

G.LEARNING & TRAINING:

Training programs have been devised to develop cross-functional skills.